TS Financial Group (TSFG)’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
DIM
PFSRSONJ
DT
BCM
KCM
CUAMC
SCM
SS
TS Financial Group (TSFG)'s BDTX Position: Q2 2026 in Review
TS Financial Group (TSFG) held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #851.
TS Financial Group (TSFG) first reported a position in BDTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1K in Q1 2024. 10 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.
- TS Financial Group (TSFG) held 100 shares of Black Diamond Therapeutics worth $0 as of Q2 2026.
- TS Financial Group (TSFG) left its Black Diamond Therapeutics share count unchanged in Q2 2026.
- Black Diamond Therapeutics made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #851 holding.
- TS Financial Group (TSFG) first reported a position in Black Diamond Therapeutics in Q3 2021 and has held it in 20 quarters since.
- TS Financial Group (TSFG)'s Black Diamond Therapeutics position peaked at $1K in Q1 2024.
- 10 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.
Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.